Abbott Laboratories ABT recently announced FDA approval for its latest version of MitraClip heart valve repair device to treat mitral regurgitation (MR). With the approval for the fourth-generation ...
Abbott Laboratories ABT recently received the CE Mark for its fourth-generation MitraClip Transcatheter Mitral Valve Repair (TMVR) System, MitraClip G4. It is a renowned minimally invasive mitral ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window BOSTON -- ...
The MitraClip G4 system provides physicians in Europe with enhancements to MitraClip's first-of-its-kind clip-based technology, building upon the device's proven delivery system. In addition to ...
The US Food and Drug Administration and Abbott are warning physicians about the potential for clip lock malfunctions with MitraClip G4 and MitraClip NTR/XTR devices. The incidents have been observed ...
Please provide your email address to receive an email when new articles are posted on . Abbott announced that a fourth-generation heart valve repair device for the treatment of patients with mitral ...
Abbott Laboratories ABT recently received the CE Mark for its fourth-generation MitraClip Transcatheter Mitral Valve Repair (TMVR) System, MitraClip G4. It is a renowned minimally invasive mitral ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback